You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Skills Training Video for Dialectical Behavior Therapy

    SBC: BEHAVIORAL TECH RESEARCH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Dialectical Behavior Therapy (DBT) is a multimodal, psychosocial treatment with demonstrated efficacy in treating borderline personality disorder (BPD). In Phase I, we developed and evaluated a pilot videotape of Marsha M. Linehan, Ph.D., teaching a DBT emotion regulation skill. Results demonstrated the videotape's efficacy at impa ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  2. HEADGEAR MONITORING FOR ORTHODONTICS

    SBC: NORTHWEST RADIOGRAPHY, P.S.            Topic: N/A

    DESCRIPTION: (taken from the abstract) The goal of this Phase II Small Business Technology Transfer Grant Application is to build and evaluate a commercial quality orthodontic Headgear Monitoring System that provides a quantitative measure of a patient's headgear use (both time and force). The Headgear Monitoring System consists of a headgear monitor, a communic ...

    STTR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  3. UTERINE TUMOR TREATMENT USING HIGH INTENSITY ULTRASOUND

    SBC: SONIC CONCEPTS, INC.            Topic: N/A

    DESCRIPTION (provided by the applicant): High Intensity Focused Ultrasound (HIFU) offers a non-invasive, non-surgical, bloodless, outpatient treatment for uterine fibroid tumors. These tumors develop in over half of all women, and account for approximately 30 percent of all hysterectomies. This proposal will develop an integrated transvaginal HIFU probe and imaging transducer for fibroid treatment ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  4. PORTABLE DEFIBRILLATOR FUZZY-LOGIC-BASED BATTERY METER

    SBC: US NANOCORP, INC.            Topic: N/A

    DESCRIPTION (provided by applicant):Reliable operation of a portable defibrillator depends critically on the "condition" of its battery. This condition is determined by available energy and at what power level this energy can be delivered to a load. With the initiative towards widespread deployment of portable defibrillators, a low-cost device capable of accurately measuring both state-of-charge ( ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  5. Field-Enhanced Carbon Monoxide Tolerance of Polymer Electrolyte Membrane (PEM) Fuel Cells

    SBC: FuelCell Energy, Inc.            Topic: N/A

    To be commercially competitive, PEM fuel cells have to be able to run on readily available fuels. Fuel reformers are practical, but fuel cell anode catalysts are severely poisoned by small quantities of carbon monoxide from the reformer. Despite mucheffort invested into increasing CO tolerance, desired performance levels have not been achieved.Our Phase I data has demonstrated excellent CO-toler ...

    STTR Phase II 2003 Department of DefenseArmy
  6. Color-Based Polyoxometalate (POM) Cellulosic Detector Strips for Chemical Warfare Agents

    SBC: Materials Technologies Corporation            Topic: ARMY03T14

    The overall objective of this Phase II program is to produce, by the end of the two-year effort, a low-cost, ready-to-use, field-deployable simple kit comprising paper, wood or plastic strips that detect the principal chemical warfare agents (CWAs) - Mustard, Sarin, Soman, and VX - in liquid as well as vapor forms, by fast and dramatic color changes. Our Phase I work produced prototype demonstra ...

    STTR Phase II 2004 Department of DefenseArmy
  7. Plasma Wave Electronics

    SBC: Sensor Electronic Technology, Inc.            Topic: ARMY03T06

    Terahertz plasma wave detectors and emitters utilizing the high-density 2-D electrons in submicron AlGaInN/GaN-based Quantum Well Heterostructure Field Effect Transistors (QW-HFETs)with high-sensitivity levels for the sensing of terahertz (THz) frequency electromagnetic radiation are proposed and developed.

    STTR Phase II 2004 Department of DefenseArmy
  8. The Virtual Observer/Controller (O/C)--- Intelligent Coaching in Dismounted Warrior Simulations

    SBC: SONALYSTS INC            Topic: ARMY03T01

    During Phase I Sonalysts, Inc., Worcester Polytechnic Institute, and Advanced Interactive Simulations, collaborated to investigate the feasibility of producing a training system that, using a simulated urban environment, supplies instructional interventions (such as real-time feedback) that are pedagogically sound and contextually relevant to the Soldier engaged in first-person simulated training. ...

    STTR Phase II 2004 Department of DefenseArmy
  9. Virulence Typing of Pseudomonas Clinical Isolates

    SBC: L2 DIAGNOSTICS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Pseudomonas aeruginosa is an opportunistic bacterial pathogen responsible for a significant proportion of serious hospital acquired infections. The organism has intrinsic resistance to most types of antibiotics and can readily acquire resistance to all clinically available antimicrobials, resulting in infections that are impossible to treat. P. aeruginosa colo ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  10. LiverTox: Advanced QSAR and Toxicogenomic Software for Hepatoxicity Prediction

    SBC: YAHSGS LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The high cost ($0.8 - $1.7 billion) and long time frames (about 13 years) required to introduce new drugs to the market contributes substantially to spiraling health care costs and diseases persisting without effective cures. A major factor is the high attrition rate of new compounds failing due to toxicity identified years into clinical trials. This particular ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government